Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Corrigan Insider Profile
4 Followers
Mark Corrigan, Director at Cubist Pharma, holds 32.23K shares in Wave Life Sciences (Ticker: WVE), holds 7.20K shares in Nabriva Therapeutics (Ticker: NBRVF), holds 0.00 shares in Cubist Pharma (Ticker: CBST).
Mark Corrigan Cubist Pharma (CBST)Director
Cubist Pharma (CBST)
Director
Not Ranked
Mark Corrigan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Mark Corrigan holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 04, 2022 - Aug 04, 2023
Return:+81.20%
The most profitable trade made by Mark Corrigan
Mark Corrigan's Trading History
Cubist Pharma
Jan 21, 2015
―
Uninformative Sell
765.10K
―
Nabriva Therapeutics
Aug 04, 2022
Director
Informative Sell
1.96K
$936.39
Novelion Therapeutics
―
―
―
―
Wave Life Sciences
Aug 14, 2024
Director
Uninformative Buy
―
$432.20K
Trevena
―
Director
―
―
CoLucid Pharmaceuticals
―
―
―
$0.00
Epirus Biopharma
Jul 17, 2014
―
Uninformative Sell
172.24K
$10.93K
Avanir Pharmaceuticals
―
―
―
―
List of latest transactions for each holding click on a transaction to see Mark Corrigan's performance on stock
You May Also Like
Mark Corrigan insider profile FAQ
What is the percentage of profitable transactions made by Mark Corrigan?
The percentage of profitable transactions made by Mark Corrigan is ―.
What is the average return per transaction made by Mark Corrigan?
The average return per transaction made by Mark Corrigan is ―.
What stocks does Mark Corrigan hold?
Mark Corrigan holds: CBST, NBRVF, NVLNF, WVE, TRVN, CLCD, EPRSQ, AVNR stocks.
What was Mark Corrigan’s latest transaction?
Mark Corrigan latest transaction was an Uninformative Buy of ―.
What was Mark Corrigan's most profitable transaction?
Mark Corrigan’s most profitable transaction was an Informative Sell of NBRVF stock on August 4, 2022. The return on the trade was 81.20%.
What is Mark Corrigan's role in Cubist Pharma?
Mark Corrigan's role in Cubist Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.